Butylphthalide for Brain Edema After Endovascular Treatment

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07528456

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07528456
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07528456. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-01 (anticipated); primary completion 2027-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Butylphthalide for Brain Edema After Endovascular Treatment
Condition
Acute Ischemic Stroke
Intervention (Drug)
Butylphthalide
Intervention (Drug)
Placebo
Lead sponsor
Nanfang Hospital, Southern Medical University (class: other)

Record details

Record id
cardio:ct-nct07528456
Content hash
9383f4ee4edb92b4db39e97f3e996714b9b46035fb6141672716c36caec766ee